$337.5m committed across 1 active facility, next covenant test Sep 30, 2026. BATL
Equity cure available.
The Borrower shall not permit the Total Net Leverage Ratio, as of the last day of each fiscal quarter (commencing with the fiscal quarter ending September 30, 2026), to be greater than the levels set forth in the following table for the applicable fiscal quarter:Read the filing on sec.gov ↗
Equity cure available.
The Borrower shall not permit the Current Ratio, as of the last day of any fiscal quarter (commencing with the fiscal quarter ending September 30, 2026), to be less than 1.0 to 1.0 for the applicable calendar month.Read the filing on sec.gov ↗
Equity cure available.
The Borrower shall not permit the Asset Coverage Ratio, as of the last day of any fiscal quarter (commencing with the fiscal quarter ending September 30, 2026), to be less than the applicable level set forth in the following table for the applicable fiscal quarter:Read the filing on sec.gov ↗
Equity cure available.
The Borrower shall not permit Liquidity, as of the last day of any fiscal quarter, to be less than the greater of (a) $10,000,000, and (b) the amount equal to the scheduled principal and interest payments for the immediately succeeding three (3) month period pursuant to Section 3.01(a).Read the filing on sec.gov ↗
Signed Jun 30, 2026
| Tranche | Size | Matures | Margin |
|---|---|---|---|
| Closing Date Term Loan | $162.5m | Dec 2029 | 650 bps |
| Discretionary Delayed Draw Term Loan | $175m | Dec 2029 | 650 bps |
Priced over Term SOFR, floor 200 bps (Term Loan B, Delayed draw term loan).
| Level | Condition | Margin | Unused fee |
|---|---|---|---|
| Level Level 1 | all times | 650 bps | n/a |
No amendments on file yet.
Email [email protected].